Mucosal NOXs, such as the NOX2 complex, NOX1, and dual oxidase 2 (DUOX2), have been considered as emerging risk factors for IBD, confirming that redox homeostasis imbalance is crucial for the pathogenesis of IBD. Here, CYBB is linked to inflammatory bowel disease.